Home›People›Frank Adell
Frank Adell

Frank Adell

Chief Executive Officer & Board Member at Cognos Therapeutics. Also a director, president and CEO at Neuro-Kinesis.

ExecutiveDirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Jul 2, 2026·Suggest an edit

About Frank Adell

Frank Adell is a chief executive officer & board member at Cognos Therapeutics.

Form D filings also name Frank Adell as a director, president and CEO at Neuro-Kinesis.

Frank Adell first appears on SEC filings in 2015.

Experience

This experience comes from Frank Adell's profile and from SEC filings. For roles taken from filings, the years are when the filings name Frank Adell in the role, so the role may have started earlier or lasted longer.

Cognos Therapeutics Inc Current
Chief Executive Officer & Board Member
2015 – Present · Inglewood, CA
Develops implantable drug delivery pumps for people with neurological diseases and cancer.
Neuro-Kinesis Corp
Director, President and CEO
2020 – 2021 · Inglewood, CA
Develops sensor-equipped surgical tools for physicians and surgeons.
Autonomous Medical Devices Incorporated
Co-Founder & Ex-Chief Executive Officer
2016 – 2021
Magnetecs Corporation
Co-Founder, Board Member & Executive Vice President
2000 – 2015
Pharmaco-Kinesis Corp
President/CEO
1999 – 2015
Newzaust Inc.
CEO
1985 – 2000

Key Colleagues at Startups

The people Frank Adell works with at each company, as listed on that company's latest Form D.

Cognos Therapeutics Inc · Form D, Jul 2, 2026
Eli Gang
Eli Gang
Director
Thomas Chen
Thomas Chen
Director
Neuro-Kinesis Corp · Form D, Jul 16, 2021
Eli Gang
Eli Gang
Director and Chief Medical Officer
Josh Shachar
Josh Shachar
Executive officer and director

Sources

  1. SECCognos Therapeutics Inc Form D, filed Jul 2, 2026
  2. SECNeuro-Kinesis Corp Form D, filed Jul 16, 2021